Antibody Therapeutics for Life

Notices

Press Release

PR Video

Notices


No Title Written by Written date Inquire
24   Dr. Lawrence Cher is presenting Tanibirumab phase IIa interim data at THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017.   Admin   2019-01-14   761  
23   Dr. Jin-San Yoo, CEO of PharmAbcine is attending to THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017.   Admin   2019-01-14   761  
22   Dr. Jin-San Yoo, CEO of PharmAbcine is joining for the ``Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology`` of Tumor Course of Harvard Medical School and for networking on September 5-8th, 2017.   Admin   2019-01-14   734  
21   Dr. Jin-San Yoo, CEO of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are requested to participate partnering meeting at INCHEON BIOPLUS 2017 - GLOBAL PARTNERING on September 13th, 2017.   Admin   2019-01-14   754  
20   Dr. Jin-San Yoo, CEO of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are requested to participate partnering meeting with Novartis BD&L on September 15th, 2017.   Admin   2019-01-14   751  
19   Dr. Jin-San Yoo, CEO of PharmAbcine will present as invited speaker at NOVARTIS GLOBAL PARTNERING CONFERENCE on September 14th, 2017.   Admin   2019-01-14   742  
18   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present as panelist at KoNECT-KDDF GLOBAL CLINICAL DEVELOPMENT FORUM on August 17th, 2017.   Admin   2019-01-14   745  
17   Dr. Lawrence Cher at Olivia Newton-Johns Cancer Wellness & Research Center/Austin Hospital is invited to present the interim data of Tanibirumab phase IIa recurrent GBM trial at 2017 SNO (Society for Neuro Oncology) meeting in San Francisco on November 16   Admin   2019-01-14   3,634  
16   PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT.   Admin   2019-01-14   19,955  
15   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present for ``Investor Relation`` at MIRAE ASSET DAEWOO SECURITIES Corporate Day on July 12th, 2017.   Admin   2019-01-14   739